68 related articles for article (PubMed ID: 23719915)
1. Immuno-based detection assays to quantify distinct mutant huntingtin conformations in biological samples.
Lotz GP; Weiss A
Methods Mol Biol; 2013; 1017():163-71. PubMed ID: 23719915
[TBL] [Abstract][Full Text] [Related]
2. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
[TBL] [Abstract][Full Text] [Related]
3. Protein aggregate characterization in models of neurodegenerative disease.
Tebbenkamp AT; Borchelt DR
Methods Mol Biol; 2009; 566():85-91. PubMed ID: 20058166
[TBL] [Abstract][Full Text] [Related]
4. Mutant huntingtin can paradoxically protect neurons from death.
Zuchner T; Brundin P
Cell Death Differ; 2008 Mar; 15(3):435-42. PubMed ID: 17975550
[TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment.
Persichetti F; Trettel F; Huang CC; Fraefel C; Timmers HT; Gusella JF; MacDonald ME
Neurobiol Dis; 1999 Oct; 6(5):364-75. PubMed ID: 10527804
[TBL] [Abstract][Full Text] [Related]
6. Huntingtin aggregates ask to be eaten.
Thoreen CC; Sabatini DM
Nat Genet; 2004 Jun; 36(6):553-4. PubMed ID: 15167929
[No Abstract] [Full Text] [Related]
7. Vulnerability of newly synthesized proteins to proteostasis stress.
Xu G; Pattamatta A; Hildago R; Pace MC; Brown H; Borchelt DR
J Cell Sci; 2016 May; 129(9):1892-901. PubMed ID: 27026526
[TBL] [Abstract][Full Text] [Related]
8. Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases.
Krainc D
Arch Neurol; 2010 Apr; 67(4):388-92. PubMed ID: 20385902
[TBL] [Abstract][Full Text] [Related]
9. Huntingtin processing in pathogenesis of Huntington disease.
Qin ZH; Gu ZL
Acta Pharmacol Sin; 2004 Oct; 25(10):1243-9. PubMed ID: 15456523
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice.
Sawada H; Ishiguro H; Nishii K; Yamada K; Tsuchida K; Takahashi H; Goto J; Kanazawa I; Nagatsu T
Neurosci Res; 2007 Apr; 57(4):559-73. PubMed ID: 17335925
[TBL] [Abstract][Full Text] [Related]
11. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation.
Biagioli M; Ferrari F; Mendenhall EM; Zhang Y; Erdin S; Vijayvargia R; Vallabh SM; Solomos N; Manavalan P; Ragavendran A; Ozsolak F; Lee JM; Talkowski ME; Gusella JF; Macdonald ME; Park PJ; Seong IS
Hum Mol Genet; 2015 May; 24(9):2442-57. PubMed ID: 25574027
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins.
Chhangani D; Upadhyay A; Amanullah A; Joshi V; Mishra A
Sci Rep; 2014 May; 4():5077. PubMed ID: 24865853
[TBL] [Abstract][Full Text] [Related]
13. Aggregate-centered redistribution of proteins by mutant huntingtin.
Swayne LA; Braun JE
Biochem Biophys Res Commun; 2007 Mar; 354(1):39-44. PubMed ID: 17208201
[TBL] [Abstract][Full Text] [Related]
14. Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.
Rousseau E; Dehay B; Ben-Haïem L; Trottier Y; Morange M; Bertolotti A
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9648-53. PubMed ID: 15210964
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
[TBL] [Abstract][Full Text] [Related]
16. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.
Arrasate M; Mitra S; Schweitzer ES; Segal MR; Finkbeiner S
Nature; 2004 Oct; 431(7010):805-10. PubMed ID: 15483602
[TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
[TBL] [Abstract][Full Text] [Related]
18. Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death.
Choi YJ; Kim SI; Lee JW; Kwon YS; Lee HJ; Kim SS; Chun W
Mol Cell Neurosci; 2012 Feb; 49(2):127-37. PubMed ID: 22122824
[TBL] [Abstract][Full Text] [Related]
19. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
[TBL] [Abstract][Full Text] [Related]
20. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
